These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 880966)

  • 21. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives.
    Lin AJ; Cosby LA; Shansky CW; Sartorelli AC
    J Med Chem; 1972 Dec; 15(12):1247-52. PubMed ID: 4635968
    [No Abstract]   [Full Text] [Related]  

  • 22. [The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
    Krüger FW; Osswald H; Walker G; Schelten E
    Z Krebsforsch; 1970; 74(4):434-47. PubMed ID: 4253315
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies as carriers of cancer chemotherapeutic agents.
    Ghose T; Blair AH; Uadia P; Kulkarni PN; Goundalkar A; Mezei M; Ferrone S
    Ann N Y Acad Sci; 1985; 446():213-27. PubMed ID: 3860152
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrastructural alterations induced by alkylating agent (R-74) in tumour cells.
    Lapis K; Benedeczky I; Bolla K
    Acta Biol Acad Sci Hung; 1967; 18(3):303-22. PubMed ID: 5600538
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of several antineoplastic compounds on the carbohydrate metabolism of transplanted tumors].
    Chil-Akopian LA
    Zh Eksp Klin Med; 1978; 18(2):49-54. PubMed ID: 685586
    [No Abstract]   [Full Text] [Related]  

  • 26. Action of radiation or alkylating agents on LSA lymphoma during growth.
    Maruyama Y
    Int J Radiat Oncol Biol Phys; 1979 Feb; 5(2):215-20. PubMed ID: 110736
    [No Abstract]   [Full Text] [Related]  

  • 27. [A strain of ascitic tumor NK-Ly, resistant to nitrosomethylurea].
    Poroshenko GG; Gor'kova SN; Evseenko LS
    Dokl Akad Nauk SSSR; 1968 Sep; 182(3):730-2. PubMed ID: 5737835
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of the anatomic locationof a tumor on its susceptibility to chemotherapy.
    Conzelman GM; Springer K
    Cancer Chemother Rep; 1969 Apr; 53(2):105-13. PubMed ID: 5799415
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
    Kulik GI
    Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alkylating derivatives of 2-amino-2-desoxy-1,3,4,6-tetraacetyl-D-glucopyranose (synthesis and experimental study)].
    Shkodinskaia EN; Trusheĭkina VI; Vasina OS; Goriunova OV; Martynov VS
    Vopr Onkol; 1979; 25(10):29-33. PubMed ID: 506177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of connective tissue stimulation in antitumor chemotherapy].
    Diadosha GF; Bulkina ZP; Kononenko LI
    Vopr Onkol; 1968; 14(9):70-3. PubMed ID: 4971964
    [No Abstract]   [Full Text] [Related]  

  • 32. Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.
    Byfield JE; Murnane J; Ward JF; Calabro-Jones P; Lynch M; Kulhanian F
    Br J Cancer; 1981 May; 43(5):669-83. PubMed ID: 7248151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for reinitiation of proliferative activity following alkylation or radiation.
    Maruyama Y
    Int J Radiat Oncol Biol Phys; 1976; 1(9-10):903-9. PubMed ID: 977421
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental adjuvant chemotherapy: an overview.
    Skipper HE
    Recent Results Cancer Res; 1986; 103():6-29. PubMed ID: 3738196
    [No Abstract]   [Full Text] [Related]  

  • 36. Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo.
    Kulkarni PN; Blair AH; Ghose TI
    Cancer Res; 1981 Jul; 41(7):2700-6. PubMed ID: 7248938
    [No Abstract]   [Full Text] [Related]  

  • 37. [The possibility of local cytostatic therapy].
    Grundmann E
    HNO; 1966 May; 14(5):129-33. PubMed ID: 5987279
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of alkylating antitumour preparations on the blood serum SH-groups under clinical and experimental conditions].
    Kulik GI; Danilenko LP
    Vrach Delo; 1966 Sep; 9():87-9. PubMed ID: 6001283
    [No Abstract]   [Full Text] [Related]  

  • 39. Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activities.
    Guclu A; Ghose T; Tai J; Mammen M
    Eur J Cancer (1965); 1976 Feb; 12(2):95-100. PubMed ID: 4329
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives.
    Lin AJ; Pardini RS; Cosby LA; Lillis BJ; Shansky CW; Sartorelli AC
    J Med Chem; 1973 Nov; 16(11):1268-71. PubMed ID: 4147836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.